Two recent publications showcase the potential of phage therapy not only in human medicine but also in aquaculture:
“A novel vibriophage vB_Vp_PvVp04 against pathogenic Vibrio parahaemolyticus and its formulation for inclusion in shrimp feed” (published in Aquaculture International). This study investigates a phage targeting V. parahaemolyticus, a key pathogen in shrimp farming, and its development into a feed additive to enhance shrimp health. DOI: 10.1016/j.virol.2025.110322
“Complete genome sequence of Vibrio diabolicus bacteriophage vB_Vc_SrVc2 and its efficacy as prophylactic phage therapy” (published in Virology). This work examines the genome of a phage targeting V. diabolicus and its potential for preventing infections in aquaculture. DOI: 10.1007/s10499-024-01097-9
We are deeply grateful to Eduardo Quiroz-Guzmán for leading these impactful studies and for allowing the Leptihn Lab to contribute. These efforts highlight the versatility of phage therapy in addressing challenges in seafood production and fostering sustainable aquaculture practices.
Congratulations to all the authors involved!
The Leptihn Lab 